Journal of Neurology Neurosurgery & Psychiatry · 2019 · 107 citations · 19 references
Life SciencesNeurologyNeuroscienceMolecular NeuroscienceNeurodegenerationProteomicsAmyotrophic Lateral SclerosisBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersClinical ProteomicsNeurodegenerative DiseasesNeurodegenerative DisordersAmyotrophic Lateral Sclerosis PathologyC-reactive Protein TestingCerebrospinal Fluid Neurodegeneration MarkersCerebrospinal Fluid SystemLongitudinal Cohort AnalysisMotor Neuron LossNeurofilament BiomarkersNeurofilament Heavy Chain
Objective To evaluate the classifier performance, clinical and biochemical correlations of cerebrospinal fluid (CSF) levels of the chitinase proteins Chitotriosidase-1 (CHIT1), Chitinase-3-like protein 1 (CHI3L1) and Chitinase-3-like protein 2 (CHI3L2) in amyotrophic lateral sclerosis (ALS). Methods CSF levels of CHIT1, CHI3L1, CHI3L2, phosphorylated neurofilament heavy chain (pNFH) and C-reactive protein were measured by ELISA in a longitudinal cohort of patients with ALS (n=82), primary lateral sclerosis (PLS, n=10), ALS-mimic conditions (n=12), healthy controls (n=25) and asymptomatic carriers of ALS-causing genetic mutations (AGC; n=5). Results CSF CHIT1, CHI3L1 and CHI3L2 were elevated in patients with ALS compared with healthy controls (p<0.001) and ALS-mimics (CHIT1, p<0.001; CHI3L1, p=0.017; CHI3L2, p<0.001). CHIT1 and CHI3L2 were elevated in ALS compared with PLS (CHIT1, p=0.021; CHI3L1, p=0.417; CHI3L2, p<0.001). Chitinase levels were similar in AGCs and healthy controls. Chitinase proteins distinguished ALS from healthy controls (area under the curve (AUC): CHIT1 0.92; CHI3L1 0.80; CHI3L2 0.90), mimics (AUC: CHIT1 0.84; CHI3L1 0.73; CHI3L2 0.88) and, to a lesser extent, PLS (AUC: CHIT 0.73; CHI3L1 0.51; CHI3L2 0.82) but did not outperform pNFH. CHIT1 and CHI3L2 correlated with disease progression rate (Pearson’s r =0.49, p<0.001; r =0.42, p<0.001, respectively). CHI3L1 correlated with degree of cognitive dysfunction ( r =−0.25, p=0.038). All chitinases correlated with pNFH. CHIT1 levels were associated with survival in multivariate models. Chitinase levels were longitudinally stable. Conclusions CSF chitinase proteins may have limited value as independent diagnostic and stratification biomarkers in ALS, but offer a window into non-autonomous mechanisms of motor neuronal loss in ALS, specifically in assessing response to therapies targeting neuroinflammatory pathways.
19
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Manuela Neumann, Deepak M. Sampathu, Linda K. Kwong et al. · Science · 2006 · 6.6K citations
Martin R. Turner, Annachiara Cagnin, Federico Turkheimer et al. · Neurobiology of Disease · 2004 · 727 citations · Full text
Ching‐Hua Lu, Corrie Macdonald‐Wallis, Elizabeth Gray et al. · Neurology · 2015 · 551 citations · Full text
The Human Chitotriosidase Gene
Rolf G. Boot, G. Herma Renkema, Marri Verhoek et al. · Journal of Biological Chemistry · 1998 · 408 citations · Full text